SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001047469-17-004134
Filing Date
2017-06-20
Accepted
2017-06-20 17:17:33
Documents
6
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 PREM14A a2232477zprem14a.htm PREM14A 1540159
2 G153842BGI001.GIF g153842bgi001.gif GRAPHIC 106173
3 G153842BGI002.GIF g153842bgi002.gif GRAPHIC 74356
4 G604248.JPG g604248.jpg GRAPHIC 15105
5 G250627.JPG g250627.jpg GRAPHIC 7153
6 G352450.JPG g352450.jpg GRAPHIC 5688
  Complete submission text file 0001047469-17-004134.txt   1828896
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PREM14A | Act: 34 | File No.: 000-23731 | Film No.: 17921532
SIC: 2833 Medicinal Chemicals & Botanical Products